Actinogen Medical Statistics

Total Valuation

ATGGF has a market cap or net worth of 97.18 million. The enterprise value is 92.67 million.

Market Cap	97.18M
Enterprise Value	92.67M

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	3.19B
Shares Outstanding	n/a
Shares Change (YoY)	+19.06%
Shares Change (QoQ)	+3.62%
Owned by Insiders (%)	14.55%
Owned by Institutions (%)	4.13%
Float	2.86B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.78
PB Ratio	17.41
P/TBV Ratio	21.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.76
EV / Sales	17.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.44

Financial Position

The company has a current ratio of 4.19, with a Debt / Equity ratio of 0.03.

Current Ratio	4.19
Quick Ratio	4.17
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-101.58

Financial Efficiency

Return on equity (ROE) is -110.77% and return on invested capital (ROIC) is -70.01%.

Return on Equity (ROE)	-110.77%
Return on Assets (ROA)	-63.83%
Return on Invested Capital (ROIC)	-70.01%
Return on Capital Employed (ROCE)	-216.19%
Weighted Average Cost of Capital (WACC)	9.31%
Revenue Per Employee	818,630
Profits Per Employee	-1.99M
Employee Count	6
Asset Turnover	0.41
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.50% in the last 52 weeks. The beta is 0.90, so ATGGF's price volatility has been similar to the market average.

Beta (5Y)	0.90
52-Week Price Change	+55.50%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	34.11
Average Volume (20 Days)	86,336

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ATGGF had revenue of 4.91 million and -11.95 million in losses. Loss per share was -0.00.

Revenue	4.91M
Gross Profit	4.91M
Operating Income	-12.27M
Pretax Income	-11.95M
Net Income	-11.95M
EBITDA	-12.04M
EBIT	-12.27M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 4.36 million in cash and 149,339 in debt, with a net cash position of 4.21 million.

Cash & Cash Equivalents	4.36M
Total Debt	149,339
Net Cash	4.21M
Net Cash Per Share	n/a
Equity (Book Value)	5.58M
Book Value Per Share	0.00
Working Capital	4.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.95 million and capital expenditures -25,596, giving a free cash flow of -10.97 million.

Operating Cash Flow	-10.95M
Capital Expenditures	-25,596
Free Cash Flow	-10.97M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -249.87% and -243.22%.

Gross Margin	100.00%
Operating Margin	-249.87%
Pretax Margin	-243.22%
Profit Margin	-243.22%
EBITDA Margin	-245.12%
EBIT Margin	-249.87%
FCF Margin	n/a

Dividends & Yields

ATGGF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.06%
Shareholder Yield	-19.06%
Earnings Yield	-12.29%
FCF Yield	-11.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ATGGF has an Altman Z-Score of 8.82 and a Piotroski F-Score of 3.

Altman Z-Score	8.82
Piotroski F-Score	3